Anika Therapeutics, Inc. (ANIK) ROI
- 2013-09-30: ROI 13.46%.
- 2013-06-30: ROI 11.75%.
- 2013-03-31: ROI 10.58%.
- 2012-12-31: ROI 9.92%.
Complete source-backed roi history.
- Available history
- 2010-12-31 to 2013-09-30
- Data captured
Historical ROI
| Date | ROI |
|---|---|
| 2013-09-30 | 13.46% |
| 2013-06-30 | 11.75% |
| 2013-03-31 | 10.58% |
| 2012-12-31 | 9.92% |
| 2012-09-30 | 8.97% |
| 2012-06-30 | 10.35% |
| 2012-03-31 | 9.22% |
| 2011-12-31 | 7.99% |
| 2011-09-30 | 6.64% |
Annual ROI
| Date | ROI |
|---|---|
| 2012-12-31 | 9.92% |
| 2011-12-31 | 7.99% |
| 2010-12-31 | 4.40% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |